REVELATION BIOSCIENCES, INC. (REVBW)
2025-06-30 | ||||
|---|---|---|---|---|
| Research and development | 1,317,980 | |||
| General and administrative | 1,143,249 | |||
| Total operating expenses | 2,461,229 | |||
| Loss from operations | -2,461,229 | |||
| Other income (expense), net | 16,803 | |||
| Change in fair value of warrant liability | -44 | |||
| Total other income (expense), net | 16,847 | |||
| Net loss | -2,444,382 | |||
| Deemed dividends | 3,181,786 | |||
| Net loss attributable to common stockholders | -5,626,168 | |||
| Earnings per share, basic, total | -7.01 | |||
| Earnings per share, diluted | -7.01 | |||
| Weighted average number of shares outstanding, basic, total | 802,670 | |||
| Weighted average number of shares outstanding, diluted | 802,670 | |||